Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery Devices

PUBLISHER: Grand View Research | PRODUCT CODE: 1571559

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1571559

UK Hypodermic Syringes And Needles Market Size, Share & Trends Analysis Report By Product (Hypodermic Syringes, Hypodermic Needles), By End-use (Hospitals, Clinics, Ambulatory Surgical Centers), And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 3950
Printable PDF (5-User License)
USD 4950
Printable PDF (Enterprise License)
USD 6950

Add to Cart

Description

Table of Contents

List of Tables

UK Hypodermic Syringes And Needles Market Growth & Trends:

The UK hypodermic syringes and needles market size is anticipated to reach USD 479.3 million by 2030, expanding at a CAGR of 16.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to factors such as the growing geriatric population, increasing prevalence of chronic disorders, and rising number of surgeries. Increasing demand for syringes for mass vaccination is the primary factor driving the demand for hypodermic syringes and needles. Moreover, an increasing number of needlestick injuries is expected to drive the market growth. According to a National Library of Medicine study published in April 2024, approximately 100,000 needlestick injuries occur annually in the UK.

Furthermore, enhancing the efficacy and safety of anesthetic administration are the growing technological developments in syringes and needle designs. The market is expanding due to innovations, including safety-engineered syringes, ultra-thin needles, and smart syringes with integrated technology. These developments aid in patient comfort, improving accuracy and lowering problems, which makes it easier for patients to accept innovative products.

Furthermore, the need for hypodermic needles and syringes is fueled by the UK's advanced healthcare system, which is comprised of modern hospitals and clinics. Investments made to modernize and enlarge medical facilities result in higher use of these hypodermic syringes. The National Health Service (NHS) finances healthcare services, which makes it easier to buy hypodermic syringes, and other contemporary medical equipment.

UK regulations demand that hypodermic syringes and needles meet high standards for patient safety, sterility, and quality. Manufacturers must adhere to guidelines set by regulatory bodies such as the Medicines and Healthcare Products Regulatory Agency (MHRA) and European Medical Device Regulation (MDR), which increase the cost and complexity of the approval process. The process of obtaining approval for medical devices such as hypodermic syringes and needles can be time-consuming due to the need for clinical testing, safety evaluations, and risk assessments.

UK Hypodermic Syringes And Needles Market Report Highlights:

  • Based on product, the hypodermic syringes segment held the largest market share in 2023. This is attributed to the quick technical developments that increase patient comfort, safety, and effectiveness during medical procedures
  • Based on end use, the hospitals segment dominated the market with the largest revenue share in 2023. This is due to their crucial role in maintaining a consistent and high demand for hypodermic needles and syringes, primarily due to the extensive number of medical procedures carried out
Show more
Product Code: GVR-4-68040-452-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources & Third-Party Perspectives
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in number of needlestick injuries
      • 3.2.1.2. Rising vaccination rates and campaigns
      • 3.2.1.3. Advancements in hypodermic syringes and needles
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product recalls and field safety notices
      • 3.2.2.2. Adverse effects associated with hypodermic needles
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. UK Hypodermic Syringes and Needles Market: Product Movement Analysis
  • 4.3. UK Hypodermic Syringes and Needles Market Size & Trend Analysis, by Product, 2018 - 2030 (USD Million)
  • 4.4. Hypodermic Syringes
    • 4.4.1. Hypodermic Syringes Market, 2018 - 2030 (USD Million)
    • 4.4.2. Conventional Syringes
      • 4.4.2.1. Conventional Syringes Market, 2018 - 2030 (USD Million)
    • 4.4.3. Safety Syringes
      • 4.4.3.1. Safety Syringes Market, 2018 - 2030 (USD Million)
      • 4.4.3.2. Retractable Safety Syringes
        • 4.4.3.2.1. Retractable Safety Syringes Market, 2018 - 2030 (USD Million)
      • 4.4.3.3. Non-retractable Safety Syringes
        • 4.4.3.3.1. Retractable Safety Syringes Market, 2018 - 2030 (USD Million)
  • 4.5. Hypodermic Needles
    • 4.5.1. Hypodermic Needles Market, 2018 - 2030 (USD Million)
    • 4.5.2. Conventional Needles
      • 4.5.2.1. Conventional Needles Market, 2018 - 2030 (USD Million)
    • 4.5.3. Safety Needles
      • 4.5.3.1. Safety Needles Market, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. UK Hypodermic Syringes and Needles Market: End Use Movement Analysis
  • 5.3. UK Hypodermic Syringes and Needles Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 5.5. Clinics
    • 5.5.1. Clinics Market, 2018 - 2030 (USD Million)
  • 5.6. Ambulatory Surgical Centers
    • 5.6.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • 5.7. Veterinary
    • 5.7.1. Veterinary Market, 2018 - 2030 (USD Million)
  • 5.8. Home Care
    • 5.8.1. Home Care Market, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Company Market Position Analysis
  • 6.3. Strategy Mapping
  • 6.4. Company Profiles/Listing
    • 6.4.1. BD (Becton, Dickinson & Corporation)
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Service Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. Cardinal Health
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Service Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. B. Braun SE
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Service Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. ICU Medical
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Service Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Terumo Corporation
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Service Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Nipro Europe Group Companies (Nipro Corporation)
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Service Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. SolM
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Service Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. GBUK Group Ltd.
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Service Benchmarking
      • 6.4.8.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-452-9

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. UK hypodermic syringes and needles market, by product, 2018 - 2030 (USD Million)
  • Table 4. UK hypodermic syringes and needles market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Market research process
  • Fig 2. Information procurement
  • Fig 3. Primary research pattern
  • Fig 4. Market research approaches
  • Fig 5. Value chain-based sizing & forecasting
  • Fig 6. Market formulation & validation
  • Fig 7. Model details
  • Fig 8. UK hypodermic syringes and needles market segmentation
  • Fig 9. Market snapshot
  • Fig 10. Segment snapshot
  • Fig 11. Competitive landscape snapshot
  • Fig 12. Market dynamics
  • Fig 13. Market driver relevance analysis (current & future impact)
  • Fig 14. Market restraint relevance analysis (current & future impact)
  • Fig 15. PESTLE analysis
  • Fig 16. Porter's five forces analysis
  • Fig 17. UK hypodermic syringes and needles market: Product outlook and key takeaways
  • Fig 18. UK hypodermic syringes and needles market: Product movement analysis
  • Fig 19. Hypodermic syringes market revenue, 2018 - 2030 (USD Million) market revenue, 2018 - 2030 (USD Million)
  • Fig 20. Conventional syringes market revenue, 2018 - 2030 (USD Million) market revenue, 2018 - 2030 (USD Million)
  • Fig 21. Safety syringes market revenue, 2018 - 2030 (USD Million) market revenue, 2018 - 2030 (USD Million)
  • Fig 22. Retractable safety syringes market revenue, 2018 - 2030 (USD Million) market revenue, 2018 - 2030 (USD Million)
  • Fig 23. Non-retractable safety syringes market revenue, 2018 - 2030 (USD Million) market revenue, 2018 - 2030 (USD Million)
  • Fig 24. Hypodermic needles market revenue, 2018 - 2030 (USD Million) market revenue, 2018 - 2030 (USD Million)
  • Fig 25. Conventional needles market revenue, 2018 - 2030 (USD Million) market revenue, 2018 - 2030 (USD Million)
  • Fig 26. Safety needles market revenue, 2018 - 2030 (USD Million)
  • Fig 27. UK hypodermic syringes and needles market: End use outlook and key takeaways
  • Fig 28. UK hypodermic syringes and needles market: End use movement analysis
  • Fig 29. Hospitals market revenue, 2018 - 2030 (USD Million) market revenue, 2018 - 2030 (USD Million)
  • Fig 30. Clinics market revenue, 2018 - 2030 (USD Million) market revenue, 2018 - 2030 (USD Million)
  • Fig 31. Ambulatory surgical centers market revenue, 2018 - 2030 (USD Million) market revenue, 2018 - 2030 (USD Million)
  • Fig 32. Veterinary market revenue, 2018 - 2030 (USD Million) market revenue, 2018 - 2030 (USD Million)
  • Fig 33. Home care market revenue, 2018 - 2030 (USD Million)
  • Fig 34. Others market revenue, 2018 - 2030 (USD Million) market revenue, 2018 - 2030 (USD Million)
  • Fig 35. Company categorization
  • Fig 36. Company market position analysis
  • Fig 37. Strategy mapping
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!